Dr Jaymi Lad presents an overview of topical tyrosinase inhibitors and topical adjuncts for hyperpigmentation treatment Hyperpigmentation encompasses a heterogeneous group of acquired and inherited pigmentary disorders characterised by excess melanin production, abnormal melanin distribution or impaired melanin transfer.¹ It …
Aesthetic nurse Kate Monteith-Ross discusses the role of exosomes and energy-based devices for treating hyperpigmentation Hyperpigmentation and hypopigmentation are significant dermatological concerns that can arise as complications following various therapeutic interventions, including the use of energy-based device treatments. These dyschromias …
Skincare company PCA Skin has launched the new Pigment Correct Peel to its portfolio. According to the company, the peel’s formulation aims to increase the skin’s cell turnover rate, bringing
Dr Abirami Pararajasingam and Dr Sandeep Cliff explore treatment for post-inflammatory hyperpigmentation in individuals with Fitzpatrick skin types III-VI.
Aesthetic laser company Lynton, in partnership with Deka, has introduced Moveo Technology to extend its offering with the Motus AY.
A recent in-vitro study has revealed that pomegranate fruit extract Pomanox may reduce signs of skin ageing.
Distribution company DermaFocus has introduced a new biostimulating injectable to its portfolio.
Medical cosmetic company Promoitalia has released V Bianco – a topical skin treatment to reduce the appearance of melanic spots.
Skincare distributor AestheticSource has launch its new Cyspera Intensive System of three skincare products designed to target hyperpigmentation and discolouration within 16 weeks.
A science-based approach to improving radiance, texture, and clarity to help correct out-of-balance skin
